Xiying Wu

Xiying Wu

Auto-generated profile, based on publicly available information

Xiying Wu

Obatala Sciences Inc., New Orleans, LA 70148, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
MMMichelle McCarthy
Michelle McCarthy
TBTheodore Brown
Theodore Brown
AAAndrea Alarcon
Andrea Alarcon
CWChristopher C Williams
Christopher C Williams
XWXiying Wu
Xiying Wu
TFTrivia Frazier
Trivia Frazier
The obesity epidemic and its associated co-morbidities present a looming challenge to health care delivery throughout the world. Obesity is characterized as a sterile inflammatory process within adipose tissues leading to dysregulated secretion of bio-active adipokines such as adiponectin and leptin as well as systemic metabolic dysfunction. The majority of current obesity research has focused primarily on pre-clinical animal models in vivo and two-dimensional (2D) cell culture models in vitro. Neither of these generalized approaches is optimal due to inter-species variability, insufficient accuracy with respect to predicting human outcomes, and failure to recapitulate the three-dimensional (3D) microenvironment. Consequently, there is a growing demand and need for more sophisticated microphysiological systems (MPS) in order to re-produce more physiologically accurate human white and brown/beige adipose depots. To address this research need, human and murine cell lines and primary cultures are being combined with bioscaffolds to create functional 3-dimensional environments that are suitable for metabolically active adipose organoids in both static and perfusion bioreactor cultures. The development of these technologies will have considerable impact on the future pace of discovery for novel small molecules and biologics designed to prevent and treat metabolic syndrome and obesity in humans. Furthermore, when these adipose tissue models are integrated with other organ systems they will have applicability to obesity-related disorders such as diabetes, non-alcoholic fatty liver disease, and osteoarthritis.

27 September 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
TFTrivia Frazier
Trivia Frazier
AAAndrea Alarcon
Andrea Alarcon
XWXiying Wu
Xiying Wu
OMOmair Mohiuddin
Omair Mohiuddin
JMJessica M. Motherwell
Jessica M. Motherwell
JGJeffrey Gimble
Jeffrey Gimble
Acute and chronic skin wounds due to burns, pressure injuries, and trauma represent a substantial challenge to healthcare delivery with particular impacts on geriatric, paraplegic, and quadriplegic demographics worldwide. Nevertheless, the current standard of care relies extensively on preventive measures to mitigate pressure injury, surgical debridement, skin flap procedures, and negative pressure wound vacuum measures. This article highlights the potential of adipose-, blood-, and cellulose-derived products (cells, decellularized matrices and scaffolds, and exosome and secretome factors) as a means to address this unmet medical need. The current status of this research area is evaluated and discussed in the context of promising avenues for future discovery.

3 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
PGPeyton Gibler
Peyton Gibler
JGJeffrey Gimble
Jeffrey Gimble
KHKatie Marie Hamel
Katie Marie Hamel
EREmma Rogers
Emma Rogers
MHMichael Henderson
Michael Henderson
TFTrivia Frazier
Trivia Frazier
Human adipose-derived stromal/stem cells (hASC) are widely used for in vitro modeling of physiologically relevant human adipose tissue. These models are useful for the development of tissue constructs for soft tissue regeneration and 3-dimensional (3D) microphysiological systems (MPS) for drug discovery. In this systematic review, we report on the current state of hASC culture and assessment methods for adipose tissue engineering using 3D MPS. Our search efforts resulted in the identification of 184 independent records, of which 27 were determined to be most relevant to the goals of the present review. Our results demonstrate a lack of consensus on methods for hASC culture and assessment for the production of physiologically relevant in vitro models of human adipose tissue. Few studies have assessed the impact of different 3D culture conditions on hASC adipogenesis. Additionally, there has been a limited use of assays for characterizing the functionality of adipose tissue in vitro. Results from this study suggest the need for more standardized culture methods and further analysis on in vitro tissue functionality. These will be necessary to validate the utility of 3D MPS as an in vitro model to reduce, refine, and replace in vivo experiments in the drug discovery regulatory process.

13 March 2012 in AGE
Verified
Journal Article
Open access
PDF file
GSGregory M. Sutton
Gregory M. Sutton
APAndrey A. Ptitsyn
Andrey A. Ptitsyn
ZFZ. Elizabeth Floyd
Z. Elizabeth Floyd
GYGang Yu
Gang Yu
XWXiying Wu
Xiying Wu
JGJeffrey Gimble
Jeffrey Gimble
Biological aging alters the metabolism and volume of adipose tissue depots. Recent evidence suggests that circadian mechanisms play a role in promoting adipogenesis, obesity, and lipodystrophy. The current study compared cohorts of younger (5–9 months) and older (24–28 months) C57BL/6 mice as a function of biological age and circadian time. Advanced age significantly reduced the weight of the brown, epididymal, inguinal, and retroperitoneal adipose depots but not total body weight. The older mice reduced their physical activity by >50% and delayed their activity initiation after light offset. The expressed transcriptome in brown and white adipose depots and liver of both cohorts displayed evidence of circadian rhythmicity; however, the oscillating mRNAs differed significantly between age groups and across tissues. The amplitude of Cry1, a component of the negative arm of the circadian apparatus, and downstream regulators such as Rev-erbα were elevated in the older relative to the younger cohorts as a function of circadian time. Overall, transcript levels differed significantly for 557 (inguinal adipose), 1,016 (liver), and 1,021 (brown adipose) expressed sequences between the cohorts as a function of age. These included transcripts encoding proteins within the canonical and non-canonical Wnt pathways. Since the Wnt pathway regulates adipose stem cell differentiation and shares a critical enzyme, glycogen synthase kinase 3β, with the circadian mechanism, the intersection between these two fundamental regulatory mechanisms merits further investigation with respect to biological aging of adipose tissues.

1 April 2021 in Tissue Engineering Part A
Verified
Journal Article
Closed access
TFTrivia Frazier
Trivia Frazier
CWChristopher C Williams
Christopher C Williams
MHMichael Henderson
Michael Henderson
TDTamika Duplessis
Tamika Duplessis
EREmma Rogers
Emma Rogers
JGJeffrey Gimble
Jeffrey Gimble
International regulatory agencies such as the Food and Drug Administration have mandated that the scientific community develop humanized microphysiological systems (MPS) as an in vitro alternative to animal models in the near future. While the breast cancer research community has long appreciated the importance of three-dimensional (3D) growth dynamics in their experimental models, there are remaining obstacles preventing a full conversion to humanized MPS for drug discovery and pathophysiological studies. This perspective evaluates the current status of human tissue-derived cells and scaffolds as building blocks for an “idealized” breast cancer MPS based on bioengineering design principles. It considers the utility of adipose tissue as a potential source of endothelial, lymphohematopoietic, and stromal cells for the support of breast cancer epithelial cells. The relative merits of potential MPS scaffolds derived from adipose tissue, blood components, and synthetic biomaterials is evaluated relative to the current “gold standard” material, Matrigel, a murine chondrosarcoma-derived basement membrane-enriched hydrogel. The advantages and limitations of a humanized breast cancer MPS are discussed in the context of in-process and destructive read-out assays.